Dr. David Dalton, CEO of Univec Inc., has been named one of the 100 Health Visionaries of 2019 by the International Forum on Health Advances. IFAH is made up of the best students in the field of health and wellness who are recognized for their contributions. According to the citation, the award was given in recognition of Dalton’s contributions to health care.
This week, Dalton was featured in Daily MicroCap, an information and research organization focused on micro and small cap stocks. According to Boe Rimes, Univec, Inc. is continuing with its growth and expansion plans, recently adding Lamont Ellis as president and Lauren Herron as vice president. They join CEO David Dalton, the first black pharmaceutical executive in the pharmaceutical industry chain.
Last year, Univec announced the acquisition of outpatient health centers in Maryland. According to MicroCap, the acquisition was expected to add more than $17 million in revenue to Univec.
In October, Univec formed a partnership with bioRemedies MD, LLC, to provide complementary therapies for pain and sleep disorders. Currently trading at a market valuation of $56 million, UNVC is up, Daily MicroCap reported.
Believe in diversity
Investing in Univec Inc. (UNVC)
Black CEO -David Dalton
in 4 Halls of Fame and
Senate Medal of Freedom, A veteran.
Former Vice President of Fortune 500 Rite Aid
Black Enterprise #22 Top 100. IFAH Recognition. Now you know. Let’s make the change.— Dr. David Dalton (@DrDavidDalton1) April 4, 2022
His daughter (Chaitra Dalton Bryant) and son-in-law (John Hope Bryant) ring the Nasdaq bell this morning. pic.twitter.com/uTjtqdu0y7
— Dr. David Dalton (@DrDavidDalton1) April 5, 2022
